Company intelligence / Profile preview

Taiwan Cell Manufacturing Company

Ownership: Private
Development stage: Commercial

Overview

TCMC is the first facility in Taiwan dedicated to the commercial-scale, PIC/S GMP-compliant manufacturing of genetically modified cell therapies and viral vectors. The company provides premium-quality lentiviral vectors and a range of cell therapy products including CAR-T, NK cells, and iPSCs for clients in the rapidly growing field of cell and gene therapy. No direct clinical trial results are reported as TCMC operates as a CDMO/CMO supporting client programs.

Therapeutic areas: Oncology
Modalities: Genetically modified cell therapies (e.g., CAR-T, NK cells, iPSCs)Lentiviral vectorsViral vectors
Industry: Contract Manufacturing Organization

Beyond the preview

Go deeper on Taiwan Cell Manufacturing Company.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Taiwan Cell Manufacturing Company.

Explore the full profile